Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans

Sponsor
University of Campinas, Brazil
Study ID
NCT02718950
Phase
PHASE3
Status
Unknown

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to access liraglutide influence brown adipose tissue recruitment and its thermogenic effect through hypothalamic activation in obese individuals.

Key Dates

Start date
Jun 30, 2016
Status verified
Mar 2016
Primary completion
Mar 31, 2017
Completion
Apr 30, 2017

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Liraglutide 3.0 mg
    Subjects will use liraglutide 3.0 mg for 2 weeks.

Primary Outcome Measure

Evaluate the effect of liraglutide administration on brown adipose tissue (BAT) activation in humans [ Time Frame: 2 weeks ]

Central Contacts

Related Studies